SIRT1 and metabolic dysfunction-associated steatotic liver disease: SIRT1 maintains the balance of fatty acid metabolism by inhibiting fatty acid synthesis, promoting fatty acid oxidation and regulating fatty acid transport (Ishizuka et al., 2020), thereby reducing the severity of MASLD and MASH (Hua et al., 2021; Yang et al., 2024b).